Persistent, therapeutically relevant levels of human granulocyte colony- stimulating factor in mice after systemic delivery of adeno-associated virus vectors

Human Gene Therapy

Volumn 10, Issue 13, 1999, Pages 2133-2140

  Koeberl, Dwight D ^a,b,c   Bonham, Lynn ^a,d   Halbert, Christine L ^a   Allen, James M ^a   Birkebak, Ted ^e   Miller, A Dusty ^a,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d Cell Therapeutics Inc   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CONTROLLED STUDY; GAMMA IRRADIATION; GENE THERAPY; HUMAN; HUMAN CELL; INJECTION; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ANIMALS; CELL COUNT; CELLS, CULTURED; DEPENDOVIRUS; FEMALE; GAMMA RAYS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; LIVER; MICE; MICE, INBRED C57BL; NEUTROPHILS;

EID: 0033198826     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017121     Document Type: Article

References (44)

1. ALEXANDER, I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effect of gamma irradiation on the transduction of dividing and nondividing cells in the brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850.
2. ALLEN, J.M., DEBELAK, D.J., REYNOLDS, T.C., and MILLER, A.D. (1997). Identification and elimination of replication-competent adeno-associated virus (AAV) that can arise by nonhomologous recombination during AAV vector production. J. Virol. 71, 6816-6822.
3. ALTMAN, D.G. (1991). Practical Statistics for Medical Research. (Chapman & Hall, London, UK) pp. 192-194.
4. BONHAM, L., PALMER, T., and MILLER, A.D. (1996). Prolonged expression of therapeutic levels of human granulocyte colony-stimulating factor in rats following gene transfer to skeletal muscle. Hum. Gene Ther. 7, 1423-1429.
5. CARTER, B., LAUGHLIN, C.A., DE LA MAZA, L.M., and MYERS, M. (1979). Adeno-associated virus autointerference. Virology 92, 449-462.
6. CHANG, J.M., METCALF, D., GONDA, T.J., and JOHNSON, G.R. (1989). Long-term exposure to retrovirally expressed granulocyte-colony-stimulating factor induces a nonneoplastic granulocytic and progenitor cell hyperplasia without tissue damage in mice. J. Clin. Invest. 84, 1488-1496.
7. DALE, D.C. (1995). Hematopoetic growth factors for the treatment of severe chronic neutropenia. Stem Cells 13, 94-100.
8. DALE, D.C., and HAMMOND, W.P., IV. (1988). Cyclic neutropenia: A clinical review. Blood Rev. 2, 178-185.
9. DALE, D.C., BONILLA, M.A., DAVIS, M.W., NAKANISHI, A.M., HAMMOND, W.P., KURTZBERG, J., WANG, W., JAKOWSKI, A., WINTON, E., LALEZARI, P., ROBINSON, W., GLASPY, J.A., EMERSON, S., GABRILOVE, J., VINCENT, M., and BOXER, L.A. (1993). A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood 81, 2496-2502.
10. DALE, D.C., RODGER, E., CEBON, J., RAMESH, N., HAMMOND, W.P., and ZSEBO, K.M. (1995). Long-term treatment of canine cyclic hematopoiesis with recombinant canine stem cell factor. Blood 85, 74-79.
11. FISHER, K.J., JOOS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med. 3, 306-312.
12. FISHER-ADAMS, G., WONG, K.K., JR., PODSAKOFF, G., FORMAN, S.J., and CHATTERJEE, S. (1996). Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction. Blood 88, 492-504.
13. GEY, G.O., COFFMAN, W.D., and KUBICEK, M.T. (1952). Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res. 12, 264.
14. GOSSEN, M., FREUNDLIEB, S., BENDER, G., MULLER, G., HILLEN, W., and BUJARD, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
15. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-72.
16. HALBERT, C.L., ALEXANDER, I.E., WOLGAMOT, G.M., and MILLER, A.D. (1995). Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J. Virol. 69, 1473-1479.
17. HERZOG, R.W., HAGSTROM, J.N., KUNG, S.H., TAI, S.J., WILSON, J.M., FISHER, K.J., and HIGH, K.A. (1997). Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 94, 5804-5809.
18. HERZOG, R.W., YANG, E.Y., COUTO, L.B., HAGSTROM, J.N., EL-WELL, D., FIELDS, P.A., BURTON, M., BELLINGER, D.A., READ, M.S., BRINKHOUS, K.M., PODSAKOFF, G.M., NICHOLS, T.C., KURTZMAN, G.J., and HIGH, K.A. (1999). Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nature Med. 5, 56-63.
19. KESSLER, P.D., PODSAKOFF, G.M., CHEN, X., McQUISTON, S.A., COLOSI, P.C., MATELIS, L.A., KURTSMAN, G.J., and BYRNE, B.J. (1996). Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc. Natl. Acad. Sci. U.S.A. 93, 14082-14087.
20. KOEBERL, D.D., ALEXANDER, I.E., HALBERT, C.L., RUSSELL, D.W., and MILLER, A.D. (1997). Persistent expression of human clotting factor IX form mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 94, 1426-1431.
21. LEIJINKS, D.V., HAN, S.W., RAMESH, N., LAU, S., and OSBORNE, W.R.A. (1996). Granulocyte colony-stimulating factor expression from transduced vascular smooth muscle cells provides sustained neutrophil increases in rats. Hum. Gene Ther. 7, 1431-1436.
22. LOTHROP, C.D., JR., WARREN, D.J., SOUZA, L.M., JONES, J.B., and MOORE, M.A. (1988). Correction of cyclic hematopoiesis with recombinant human granulocyte colony-stimulating factor. Blood 72, 1324-1328.
23. LUSKY, M., and BOTCHAN, M. (1981). Inhibition of SV40 replication in simian cells by specific pBR322 DNA sequences. Nature (London) 293, 79-81.
24. MIAO, C.H., SNYDER, R.O., SCHOWALTER, D.B., PATIJN, G.A., DONAHUE, B., WINTHER, B., and KAY, M.A. (1998). The kinetics of rAAV integration in the liver. Nature Genet. 19, 13-15.
25. MIGLIACCIO, A.R., MIGLIACCIO, G., DALE, D.C., and HAMMOND, W.P. (1990). Hematopoietic progenitors in cyclic neutropenia: Effect of granulocyte colony-stimulating factor in vivo. Blood 75, 1951-1959.
26. MISHU, L., CALLAHAN, G., ALLEBBAN, Z., MADDUX, J.M., BOONE, T.C., SOUZA, L.M., and LOTHROP, C.D., JR. (1992). Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs. JAMA 200, 1957-1964.
27. NO, D., YAO, T.P., and EVANS, R.M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93, 3346-3351.
28. PALMER, S.E., DALE, D.C., LIVINGSTON, R.J., WIJSMAN, E.M., and STEPHENS, K. (1994). Autosomal dominant cyclic hematopoiesis: exclusion of linkage to the major hematopoietic regulatory gene cluster on chromosome 5. Hum. Genet. 93, 195-197.
29. PINKERT, C.A., ORNITZ, D.M., BRINSTER, R.L., and PALMITER, R.D. (1987). An albumin enhancer located 10 kb upstream functions along with its promoter to direct efficient, liver-specific expression in transgenic mice. Genes Dev. 1, 268-276.
30. RENDAHL, K.G., LEFF, S.E., OTTEN, G.R., SPRATT, S.K., BOHL, D., VAN ROEY, M., DONAHUE, B.A., COHEN, L.K., MANDEL, R.J., DANOS, O., and SNYDER, R.O. (1998). Regulation of gene expression in vivo following transduction by two separate rAAV vectors. Nature Biotechnol. 16, 757-761.
31. ROSENTHAL, F.M., KULMBURG, P., FRUH, R., PFEIFER, C., VEELKEN, H., MACKENSEN, A., KOHLER, G., LINDEMANN, A., and MERTELSMANN, R. (1996). Systemic hematological effects of granulocyte colony-stimulating factor produced by irradiated gene-transfected fibroblasts. Hum. Gene Ther. 7, 2147-2156.
32. SAMULSKI, R.J., CHANG, L.-S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
33. SEKI, M., and INOUE, T. (1990). Granulocytic leukemia, mouse. In Monographs on Pathology of Laboratory Animals, Hematopoietic System. T.C. Jones, J.M. Ward, U. Mohr, and R.D. Hunt, eds. (Springer-Verlag, New York) pp. 46-50.
34. SNYDER, R.O., MIAO, C.H., PATIJN, G.A., SPRATT, S.K., DANOS, O., NAGY, D., GOWN, A.M., WINTHER, B., MEUSE, L., COHEN, L.K., THOMPSON, A.R., and KAY, M.A. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nature Genet. 16, 270-276.
35. SNYDER, R.O., MIAO, C.H., MEUSE, L., TUBB, J., DONAHUE, B.A., LIN, H.-F., STAFFORD, D.W., PATEL, S., THOMPSON, A.R., NICHOLS, T., READ, M.S., BELLINGER, D.A., BRINKHOUS, K.M., and KAY, M.A. (1999). Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nature Med. 5, 64-70.
36. SPENCER, D.M., WANDLESS, T.J., SCHREIBER, S.L., and CRABTREE, G.R. (1993). Controlling signal transduction with synthetic ligands. Science 262, 1019-1024.
37. WANG, X.-S., KHUNTIRAT, B., QING, K., PONNAZHAGAN, S., KUBE, D.M., ZHOU, S., DWARKI, V.J., and SRIVASTAVA, A. (1998). Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J. Virol. 72, 5472-5480.
38. WANG, Y., O'MALLEY, B.W., JR., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. U.S.A. 91, 8180-8184.
39. WANG, Y., DEMAYO, F.J., TSAI, S.Y., and O'MALLEY, B.W. (1997). Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnol. 15, 239-243.
40. WELTE, K., ZEIDLER, C., REITER, A., MULLER, W., ODENWALD, E., SOUZA, L., and RIEHM, H. (1990). Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood 75, 1056-1063.
41. WU, P., PHILLIPS, M.I., BUI, J., and TERWILLIGER, E.F. (1998). Adeno-associated virus vector-mediated transgene integration into neurons and other nondividing cell targets. J. Virol. 72, 5919-5926.
42. XIAO, W., BERTA, S.C., LU, M.M., MOSCIONI, A.D., TAZELAAR, J., and WILSON, J.M. (1999). Adeno-associated virus as a vector for liver-directed gene therapy. J. Virol. 72, 10222-10226.
43. YAMADA, T., KANEKO, H., IIZUKA, K., MATSUBAYASHI, Y., KOKAI, Y., and FUJIMOTO, J. (1996). Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab. Invest. 74, 384-394.
44. ZEITLIN, P.L., LU, L., RHIM, J., CUTTING, G., STETTEN, G., KIEFFER, K.A., CRAIG, R., and GUGGINO, W.B. (1991). A cystic fibrosis bronchial epithelial cell line: Immortalization by adeno-12-SV40 infection. Am. J. Respir. Cell Mol. Biol. 4, 313-319.